Schedule 13G ownership disclosure

Mineralys Therapeutics Inc

Security class unavailable · CUSIP: 603170101

Event date: 2024-02-12

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
6.4000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-24-037563
Form type
SC 13G
Filer
Mineralys Therapeutics, Inc.
CIK
CIK 1933414
Filed
Feb 15, 2024
Reporting period
Feb 12, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub